Daniel Castellano

🌐 Big news: The 6th OncoAlert 🚨Colloquium is NOW AVAILABLE IN YOUR LANGUAGE!! 🇪🇸🇮🇳🇵🇹🇮🇹🇫🇷🇺🇦🇯🇵🇲🇽🇸🇦🇷🇺and many more SPOKEN & WITH CAPTIONS in 1⃣8⃣Languages ALL VIDEOS HERE 👇👇oncoalert360.com/multi-language… Top oncology experts. Global reach. Zero barriers. Watch the 50-sec video to learn how #BreastCancer @hoperugo🇺🇸 @matteolambe🇮🇹 @Icro_Meattini🇮🇹 Dr. Roberto Salgado 🇧🇪 @ErikaHamilton9 🇺🇸 @DrSGraff 🇺🇸 @itrisabel🇪🇸 @ESSOnews @ElisaAgostinett 🇧🇪 @RebeccaDSing 🇸🇬 @LazarPo31787807 🇷🇸 #LungCancer @GlopesMd🇺🇸 @jillfeldman4 🇺🇸 @UmbertoMalapel1 🇮🇹 @BRicciutiMD 🇺🇸 @UOzkerim 🇹🇷 @DrMirallas🇺🇸 GU Oncology @brian_rini 🇺🇸 @declangmurphy 🇦🇺 @KidneyCancer🇺🇸 @salvolarosa @Silke_Gillessen🇨🇭 @RenuEapen🇦🇺 @nataliagandur 🇦🇷 @seanmcbride 🇺🇸 @jAvallejo 🇪🇸@GuardConsortium GI Oncology @BenWestphalen 🇩🇪 @graokane 🇮🇪 @GIMedOnc🇺🇸 @NiuSanford 🇺🇸 @ARosen380 🇺🇸 @Erman_Akkus 🇹🇷 @realbowtiedoc 🇺🇸 GynOnc @NicoloBizzarri 🇮🇹Vanda Salutari 🇮🇹 @AStrojnaMD 🇩🇪Alejandra Martinez 🇫🇷 @CoquardRay 🇫🇷Christina Fotopoulou 🇬🇧Giorgia Garganesse 🇮🇹 @ChargariC 🇫🇷 @PaulJiL H&N🇬🇧 @DrJasonWestin Lymphoma🇺🇸 @FadiHaddad_MD Leukemia🇺🇸 @Abdallah81MD Multiple Myeloma🇺🇸 @NassifElise Sarcoma 🇺🇸 @DrBetofMDPhD Melanoma🇺🇸 Our Partners @ESGO_society @ESSOnews @CancerCareMASCC @SIOGorg Our Collaborators @APCCC_Lugano @gu_onc @Uromigos and more and more to come.......

COLLEAGUES AT #EAU26 Our friends from @GuardConsortium 🇪🇸Deliver another Great Informational Capsule, this time direct from #GU26 🇺🇸 We are proud to introduce our Colleague @mjuanfi81 Discussing the Presentation of: KEYNOTE-B15/EV 304 The phase 3 KEYNOTE-B15 trial evaluated perioperative enfortumab vedotin plus pembrolizumab versus standard cisplatin-based chemotherapy in 808 patients with muscle-invasive #BladderCancer eligible for cisplatin. The combination reduced recurrence or progression risk by 47% and improved pathologic complete response rates (56% vs 32.5%). Although higher-grade toxicities occurred, results suggest this regimen may improve survival and represent a potential new perioperative standard, warranting further comparative investigation. buff.ly/LIBgTVi @cdanicas @dralvaropinto @drenriquegrande @nachoduranm @DrJaVallejo @abraocantoMD @docjavip @AlvarezMa89031 @DrFelixGuerrero @BerUrologia @AnaPlatabello1 @AlvarezMa89031 @scocmem @OncBrothers @Helena_de_Palma @F_lopez_campos @Dav_Lorente @EurUrolOncol @tompowles1